BJH - volume 11, issue Abstract Book BHS, february 2020
F. Andreozzi , I. Dufour , A. Sogorb , S. Chabert , G. Verstraete MD, J. Raedemaeker , L. Bamps , S. Bailly MD, F. Jamar , F. Lecouvet , A. Camboni MD, PhD, J-P. Defour PhD, dr. A-C. Pouleur , J. Morelle MD, PhD, M.C. Vekemans MD
BJH - volume 11, issue Abstract Book BHS, february 2020
K. Bennis , T. Schubert , F. Jamar , D. Maisin , A. Camboni MD, PhD, S. Aydin , F. Lecouvet , M.C. Vekemans MD
BJH - volume 11, issue Abstract Book BHS, february 2020
I. Dufour , G. Verstraete MD, J. Raedemaeker , F. Andreozzi , L. Bamps , S. Chabert , A. Sogorb , S. Bailly MD, E. Van den Neste MD, PhD, X. Theunssens , F. Tamirou , D. Tennstedt , A. Camboni MD, PhD, M.C. Vekemans MD
BJH - volume 11, issue Abstract Book BHS, february 2020
J. Raedemaeker , F. Andreozzi , I. Dufour , L. Bamps , G. Verstraete MD, S. Chabert , S. Bailly MD, D. Maisin , J-P. Defour PhD, A. Camboni MD, PhD, dr. A-C. Pouleur , B. Gerber , F. Lecouvet , M.C. Vekemans MD
BJH - volume 10, issue 6, october 2019
E. Van Valckenborgh PhD, M. Bakkus PhD, E. Boone PhD, A. Camboni MD, PhD, J-P. Defour PhD, B. Denys MD, H. Devos MD, L. Dewispelaere MD, G. Froyen PhD, A. Hébrant PhD, P. Heimann MD, PhD, P. Hermans MD, PhD, E. Heylen PhD, K. Jacobs PhD, F. Lambert MD, M. Le Mercier Apr, PhD, E. Lierman PhD, H. Louagie MD, PhD, B. Maes MD, PhD, M-B. Maes PhD, G. Martens MD, PhD, L. Michaux MD, PhD, F. Nollet PhD, MSc, H.A. Poirel MD, PhD, G. Raicevic PhD, P. Saussoy MD, PhD, T. Tousseyn MD, PhD, M. Van Den Bulcke PhD, P. Vandenberghe MD, PhD, K. Vandepoele PhD, P. Vannuffel PhD, T. Venken PhD, K. Vermeulen PhD
Molecular diagnostics have an increasing impact on diagnosis, risk stratification and targeted treatment in haemato-oncology. In the framework of a pilot study for the implementation of next-generation sequencing in the Belgian healthcare system, the Commission of Personalised Medicine was founded to give professional and evidence-based advice on the molecular analysis in haemato-oncology. This paper describes its recommendations for NGS analysis in myeloid malignancies. In addition, the minimally required set of genes that must be analysed is defined and algorithms for molecular workflow in myeloid malignancies are proposed.
(BELG J HEMATOL 2019;10(6):241–9)
Read moreBJH - 2018, issue Abstract Book BHS, february 2018
S. Bailly MD, Y. Breners , S. Amat , L. Maindiaux , F. Dall’Armellina , C. Galant , A. Camboni MD, PhD, M. Coyette , E. Van den Neste MD, PhD, M.C. Vekemans MD
BJH - 2018, issue Abstract Book BHS, february 2018
A. Capes , F. Dall’Armellina , Y. Berners , L. Maindiaux , T. Connerotte MD, A. Camboni MD, PhD, P. Saussoy MD, PhD, J-P. Defour PhD, X. Poiré MD, PhD, N. Straetmans MD, PhD, M.C. Vekemans MD
Top
